Back to search
Adherence to Glaucoma Therapy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Adherence to Glaucoma Therapy trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Adherence to Glaucoma Therapy trials you may qualify forThe goal of this randomized, parallel-group, controlled trial is to compare methods of improving linkage-to-care for participants in the Village Integrated Eye…
The goal of this real-life, national, multicentre, prospective clinical investigation is to describe the adherence rate over time in patients with glaucoma alre…
The goal of this clinical trial is to evaluate whether a structured blinking exercise can improve symptoms and signs of dry eye disease (DED) in adults with gla…
Glaucoma is the second leading cause of visual impairment worldwide. Eye drop medications reduce vision loss from glaucoma by at least 60%, but eye drops must b…
To present the clinical outcomes of diurnal IOP monitoring and determine its value in our clinical practice.We reviewed the records of 1500 patients (glaucoma s…